CGCN GROUP, LLC lobbying for ERADIVIR

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Income

$20,000.00

What the client paid this registrant for the period.

Client based in

Indiana

Official filing document

Government bodies contacted 3

Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

HR 10545
American Relief Act, 2025

Lobbying activity 3

Budget/Appropriations

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.

Disaster Planning/Emergencies

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.

Health Issues

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.